Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK
GUANGZHOU, China and BAD VILBEL, Germany I May 28, 2024 I Bio-Thera Solutions (688177:SH), a commercial-stage biopharmaceutical company developing a
Source: pipelinereview.com